MDGL logo

Madrigal Pharmaceuticals (MDGL)

Profile

Full Name

Madrigal Pharmaceuticals, Inc.

Ticker Symbol

MDGL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 6, 2007

Indexes

Not included

Website

http://www.madrigalpharma.com

Employees

528

Key Details

Price

$302.06(-5.93%)

Market cap

$6.67B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$180.13M

Annual EPS

-$21.90(-9.55% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$302.06
MDGL price is $302.06

30-Day Relative Volume

1.24
MDGL 30-day relative volume is 1.24

Price Performance

Price Today change

-5.93%
MDGL price is down -5.93% today

Price YTD change

-2.11%
MDGL price is down -2.11% since January 1st

Price 1-year change

+29.65%
MDGL price is up +29.65% year-on-year

Price 3-year change

+280.09%
MDGL price is up +280.09% over the past 3 years

Price Range

Price All-time high

$415.80
MDGL price is currently -27.35% below its historical high of $415.80

Price 3-year low

$57.15
MDGL price is currently +428.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.67B
MDGL market capitalization is $6.67 billion

Market cap 3-year change

+390.69%
MDGL market capitalization is up +390.69% over the past 3 years

Market cap All-time high

$7.97B
MDGL market capitalization is currently -16.33% below its historical high of $7.97 billion

Market cap sector rank

90.71%
MDGL market capitalization is higher than 90.71% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.29%
MDGL shares outstanding is up +5.29% year-on-year

Shares Outstanding 3-Year Change

+29.1%
MDGL shares outstanding is up +29.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
MDGL beta is 0.79

200-day SMA

$289.32
MDGL price is currently +4.40% above its 200-day simple moving average

50-day SMA

$331.58
MDGL price is currently -8.90% below its 50-day simple moving average

RSI

48.09
MDGL 14-day relative strength index is 48.09

Volume

1.24
MDGL 30-day relative volume is 1.24

ATR

$18.79
MDGL average true range is $18.79

10-day Historical Volatility

44.14%
MDGL 10-day historical volatility is 44.14%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$180.13M
MDGL annual revenue is $180.13 million

Revenue Analysts estimate

$587.00M
MDGL annual revenue is currently -69.31% lower than the consensus analysts' forecast

Revenue 1-year change

-
MDGL annual revenue 1-year change is unknown

Revenue Sector rank

62.35%
MDGL annual revenue is higher than 62.35% of companies in Healthcare sector

EPS

EPS

-$21.90
MDGL annual earnings per share is -$21.90

EPS Analysts estimate

-$12.41
MDGL annual earnings per share is currently +76.41% higher than the consensus analysts' forecast

EPS 1-year change

-9.55%
MDGL annual earnings per share is down -9.55% year-on-year

EPS Sector rank

6.55%
MDGL annual earnings per share is higher than 6.55% of companies in Healthcare sector

Profit

Gross profit

$173.90M
MDGL annual gross profit is $173.90 million

Gross margin

96.54%
MDGL annual gross profit margin is 96.54%

Operating profit

-$497.88M
MDGL annual operating income is -$497.88 million

Operating margin

-276.39%
MDGL annual operating profit margin is -276.39%

Net income

-$465.89M
MDGL annual net profit is -$465.89 million

Net margin

-258.64%
MDGL annual net profit margin is -258.64%

Expenses

Total expenses

$678.01M
MDGL annual total expenses is $678.01 million

Operating expenses

$671.77M
MDGL annual total operating expenses is $671.77 million

Cost of goods sold

$6.23M
MDGL annual cost of goods sold is $6.23 million

Selling, general & administrative expenses

$435.06M
MDGL annual SGA is $435.06 million

Depreciation and amortization

$1.10M
MDGL annual depreciation & amortization is $1.10 million

Interest expense

$14.67M
MDGL annual interest expense is $14.67 million

Income tax

-
MDGL annual income tax value is unknown

EBIT & EBITDA

EBIT

-$451.22M
MDGL annual earnings before interest & taxes is -$451.22 million

EBITDA

-$450.13M
MDGL annual EBITDA is -$450.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.04B
MDGL annual total assets is $1.04 billion

Non current assets

$9.32M
MDGL annual long term assets is $9.32 million

Current assets

$1.03B
MDGL annual total current assets is $1.03 billion

Cash and cash equivalents

$100.02M
MDGL annual cash & cash equivalents is $100.02 million

Accounts receivable

$53.82M
MDGL annual accounts receivable is $53.82 million

Inventory

$34.07M
MDGL annual inventory is $34.07 million

Liabilities

Total liabilities

$287.86M
MDGL annual total liabilities is $287.86 million

Long term liabilities

$118.59M
MDGL annual total long term liabilities is $118.59 million

Current liabilities

$169.28M
MDGL annual total current liabilities is $169.28 million

Accounts payable

$43.60M
MDGL annual accounts payable is $43.60 million

Debt

Total debt

$119.57M
MDGL annual total debt is $119.57 million

Total debt 1-year change

+2.03%
MDGL annual total debt is up +2.03% year-on-year

Long term debt

$118.59M
MDGL annual long term debt is $118.59 million

Short term debt

$983.00K
MDGL annual short term debt is $983.00 thousand

Equity & Capital

Shareholders equity

$754.38M
MDGL annual stockholders equity is $754.38 million

Book value

$754.38M
MDGL annual book value is $754.38 million

Retained earnings

-$1.80B
MDGL annual retained earnings is -$1.80 billion

Working capital

$863.65M
MDGL annual working capital is $863.65 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$455.57M
MDGL annual cash flow from operations is -$455.57 million

Cash from operations 1-year change

-40.51%
MDGL annual cash flow from operations is down -40.51% year-on-year

Cash from investing

-$274.39M
MDGL annual cash flow from investing activities is -$274.39 million

Cash from investing 1-year change

+45.4%
MDGL annual cash flow from investing activities is up +45.4% year-on-year

Cash from financing

$735.06M
MDGL annual cash flow from financing activities is $735.06 million

Cash from financing 1-year change

+23.52%
MDGL annual cash flow from financing activities is up +23.52% year-on-year

CAPEX

CAPEX

$6.46M
MDGL annual capital expenditures is $6.46 million

CAPEX 1-year change

+336.92%
MDGL annual capital expenditures is up +336.92% year-on-year

Free Cash Flow

Free cash flow

-$462.03M
MDGL annual free cash flow is -$462.03 million

Free cash flow 1-year change

-41.85%
MDGL annual free cash flow is down -41.85% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

96.54%
MDGL annual gross profit margin is 96.54%

Operating margin

-276.39%
MDGL annual operating profit margin is -276.39%

Net margin

-258.64%
MDGL annual net profit margin is -258.64%

ROA & ROE

ROA

-55.37%
MDGL annual return on assets is -55.37%

ROE

-80.35%
MDGL annual return on equity is -80.35%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MDGL price to earnings ratio value is unknown

PE ratio Sector rank

-
MDGL price to earnings ratio is unknown

PB Ratio

PB ratio

8.84
MDGL price to book ratio is 8.84

PB ratio Sector rank

91.28%
MDGL price to book ratio is higher than 91.28% of companies in Healthcare sector

PS Ratio

PS ratio

37.03
MDGL price to sales ratio is 37.03

PS ratio Sector rank

90.51%
MDGL price to sales ratio is higher than 90.51% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.69B
MDGL enterprise value is $6.69 billion

Enterprise value Sector rank

89.99%
MDGL enterprise value is higher than 89.99% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-14.86
MDGL EV/EBITDA is -14.86

EV/EBITDA Sector rank

8.36%
MDGL EV/EBITDA is higher than 8.36% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.10
MDGL annual current ratio is 6.10

Quick ratio

5.90
MDGL annual quick ratio is 5.90

Leverage

Debt to equity

0.16
MDGL annual debt to equity ratio is 0.16

Interest coverage ratio

-30.76
MDGL annual interest coverage ratio is -30.76

Risk & Stability

Piotroski F-Score

-
MDGL piotroski f-score value is unknown

Altman Z-Score

11.22
MDGL altman z-score is 11.22

Analyst ratings

Recent major analysts updates

Feb 27, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Citigroup
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Jan 10, 25 JMP Securities
Market Outperform
Nov 20, 24 Cantor Fitzgerald
Neutral
Nov 5, 24 B. Riley Securities
Neutral
Nov 1, 24 UBS
Buy
Oct 23, 24 Oppenheimer
Outperform
Oct 22, 24 HC Wainwright & Co.
Buy
Oct 11, 24 Cantor Fitzgerald
Neutral

Institutional Ownership

Similar stocks

RGEN logo
Repligen (RGEN)
LNTH logo
Lantheus Holdings (LNTH)
ROIV logo
Roivant Sciences (ROIV)
HQY logo
HealthEquity (HQY)
BIO logo
Bio-Rad Laboratories (BIO)
CORT logo
Corcept Therapeutics Incorporated (CORT)
TEM logo
Tempus AI (TEM)
ENSG logo
Ensign (ENSG)
RVMD logo
Revolution Medicines (RVMD)
  • What is the ticker symbol for Madrigal Pharmaceuticals?
  • Does Madrigal Pharmaceuticals pay dividends?
  • What sector is Madrigal Pharmaceuticals in?
  • What industry is Madrigal Pharmaceuticals in?
  • What country is Madrigal Pharmaceuticals based in?
  • When did Madrigal Pharmaceuticals go public?
  • Is Madrigal Pharmaceuticals in the S&P 500?
  • Is Madrigal Pharmaceuticals in the NASDAQ 100?
  • Is Madrigal Pharmaceuticals in the Dow Jones?
  • When was Madrigal Pharmaceuticals's last earnings report?
  • When does Madrigal Pharmaceuticals report earnings?
  • Should I buy Madrigal Pharmaceuticals stock now?

What is the ticker symbol for Madrigal Pharmaceuticals?

The ticker symbol for Madrigal Pharmaceuticals is NASDAQ:MDGL

Does Madrigal Pharmaceuticals pay dividends?

No, Madrigal Pharmaceuticals does not pay dividends

What sector is Madrigal Pharmaceuticals in?

Madrigal Pharmaceuticals is in the Healthcare sector

What industry is Madrigal Pharmaceuticals in?

Madrigal Pharmaceuticals is in the Biotechnology industry

What country is Madrigal Pharmaceuticals based in?

Madrigal Pharmaceuticals is headquartered in United States

When did Madrigal Pharmaceuticals go public?

Madrigal Pharmaceuticals's initial public offering (IPO) was on February 6, 2007

Is Madrigal Pharmaceuticals in the S&P 500?

No, Madrigal Pharmaceuticals is not included in the S&P 500 index

Is Madrigal Pharmaceuticals in the NASDAQ 100?

No, Madrigal Pharmaceuticals is not included in the NASDAQ 100 index

Is Madrigal Pharmaceuticals in the Dow Jones?

No, Madrigal Pharmaceuticals is not included in the Dow Jones index

When was Madrigal Pharmaceuticals's last earnings report?

Madrigal Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does Madrigal Pharmaceuticals report earnings?

The next expected earnings date for Madrigal Pharmaceuticals is May 7, 2025

Should I buy Madrigal Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page